Appointment booking for Dr. Thomas Caughlan, MD is currently not available.Dr. Thomas Caughlan, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Thomas Caughlan, MD (he/him) is a Internist in Kalispell, MT with over 18 years of experience. What is your opinion of Dr. Thomas Caughlan, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Thomas Caughlan, MD has received over $1,716 which includes payments from the following companies:
$427.15 from Amgen Inc.
$207.20 from Genentech USA, Inc.
$180.17 from LILLY USA, LLC
$167.52 from Pfizer Inc.
$152.09 from Novartis Pharmaceuticals Corporation
$109.47 from GlaxoSmithKline, LLC.
$85.28 from sanofi-aventis U.S. LLC
$78.07 from Merck Sharp & Dohme Corporation
$66.02 from AbbVie, Inc.
$37.83 from AstraZeneca Pharmaceuticals LP
$30.44 from Radius Health, Inc.
$24.56 from Janssen Pharmaceuticals, Inc
$22.98 from Horizon Pharma plc
$21.69 from Regeneron Healthcare Solutions, Inc.
$21.65 from Janssen Biotech, Inc.
$16.21 from Sanofi Pasteur Inc.
$15.90 from Mallinckrodt LLC
$14.79 from Purdue Pharma L.P.
$13.80 from Takeda Pharmaceuticals U.S.A., Inc.
$13.39 from Iroko Pharmaceuticals, LLC
Payments received by Dr. Thomas Caughlan, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!